A three-step synthesis was used to prepare several symmetrically substituted 1,4-bis [(aminoalkyl) amino]-5,8-dimethylanthracene-9, 10-diones commencing from 3,6-difluorophthalic anhydride.
Introduction
Synthetic routes to anthracenediones having specific substitution patterns have been a major interest in organic chemistry for more than a decade. 1 The synthesis and antineoplastic evaluations of a number of symmetrically substituted 1,4-bis [(aminoalkyl) amino] anthracene-9, 10-diones have been reported. [1] [2] [3] [4] [5] In particular, ametantrone (1), and its 5,8-dihydroxy-substitued congener, mitoxantrone (2), have shown outstanding antineoplastic activity. [2] [3] [4] [5] Although 2 is widely used clinically in the management of leukemias and lymphomas, it suffers from the toxic side effects of myelosupression and cardiotoxicity.
The cell killing effects of 2 are probably multimodal in nature. 6, 7 It has been suggested that intercalation 8 into DNA is a major cellular event and that this intercalative interaction may serve for the disruption of DNA-protein interactions, specifically the interference with topoisomerase II. 9, 10 Consequently, these drugs may be considered as having a DNA intercalation domain (the anthracene-9,10-dione region) with the protonated distal amino side-arms forming hydrogen bonds between the polar phosphate groups of the DNA backbone which stabilize the DNA-drug complex. Mitoxantrone 2 has a higher DNA binding constant and a 10-fold greater therapeutic efficacy in comparison with ametantrone (3). On the other hand the evaluation of molecules with non-polar substitutents in the carbocyclic A-ring to assess the importance of DNA binding, in particular intercalation, have not been reported. The goal of this research was the synthesis and antitumor evaluations of molecules related to 2 but with lipophilic (non-polar groups such as methyl groups) constituents as C-1 and C-4. The DNA interaction (binding constants) and antitumor activities of these molecules would be determined and contrasted to exhibited by mitoxantrone 2 and related chemotypes. This data could lead to a better understanding of the electronic and steric requirements for substrates in the intercalative action with DNA. Our efforts were directed toward the synthesis of analogue 3 in which the 5,8-hydroxyl groups of mitoxantrone 2 have been replaced by methyl groups. Congeners 4 and 5, bearing the same methyl substitution pattern would also be prepared and biologically evaluated to assess the influence of the distal side arms on DNA binding and antitumor activity.
The synthetic pathway leading to the difluoro analogue 9 (the precursor to 3, 4 and 5) is illustrated in Scheme 1. Difluoro analogue 9 appeared to be the ideal intermediate for the preparation of chemotypes 3, 4, and 5 based on the relatively facile SNAr displacements by amines of fluorides in related difluoranthracenediones 11 and azaanthracenediones. 12 The keto acid 8 (71%) was readily obtained via a Friedel-Crafts acylation of p-xylene (6) with 3,6-difluorophthalic anhydride (7).
13 Subsequent ring closure of the keto acid 8 with polyphosphoric acid led to 9. It might be noted that the aryne route 14 leading to anthracene-9,10-diones might be adaptable for the synthesis of 9.
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Scheme 1
Treatment of 9 with 2-(2-aminoethylamino) ethanol (3 molar equivalent excess) in DMSO at room temperature for 72 h afforded the disubstituted product 3 (Scheme 2) which was purified by recrystallization. Although displacements of the fluorides were rapid, the long reaction time led to complete conversion to the product. Analogues 4 and 5 were obtained in a similar manner by treatment of 9 with the appropriate amines and were purified by crystallization and chromatography, respectively.
Scheme 2
The biological activities for the synthetics 3, 4 and 5 (and their corresponding hydrochloride or dimaleate salts) will be reported elsewhere.
Experimental Section
General Procedures. Melting points were determined on a Thomas-Hoover melting point apparatus and are uncorrected. C for 1 h. The black solution was cooled in an ice bath for 1h. Upon the addition of cold water (10 mL), the solution turned from black to afford a yellow suspension. Concentrated HCl (2 mL) was added to bring the pH to 1. Ether (5 mL) and cold water (5 mL) were added, and the organic layer was separated and washed with cold water. The keto acid was extracted from the organic layer with 10% NaOH (2 mL). The aqueous layer was separated, and the organic layer was extracted with further 1 mL portions of 10% NaOH. The aqueous extracts were combined, acidified to pH 1-2, cooled in an ice bath and the keto acid was collected by filtration (560 mg, 71%); mp 151- 
